Academic Sector Leverages Open-Source Concept in Development

Alex Philippidis | Genetic Engineering & Biotechnology News | October 11, 2011

Biopharma companies are pursuing open-innovation collaborations with an eye on speeding up research and discovery work. Academic and independent research institutions are also teaming up with industry to discover new treatments under this open-source model.

Cost-cutting pressures and the desire for faster-to-market medicine are some of the driving forces behind open-collaboration efforts. Academic-based organizations seem so far to focus more on strengthening clinical development and improving research infrastructure, namely through data sharing initiatives...